Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2026-06-05 18:04:03 ET · period of report 2026-06-04 · accession 0001193125-26-260084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-05 18:04 | 2026-06-04 | INKT | Ryan Barbara | Dir | S - Sale | $12.76 | -1,500 | 22.0K | -6% | -$19.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-04 | S | D | 500 | $12.68 | 22,969 | D | — | — | (F1) The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. |
| 2 | Common | Common Stock | 2026-06-04 | S | D | 1,000 | $12.80 | 21,969 | D | — | — | (F1) The reported transaction reflects the sale of Common Stock received by Ms. Ryan as compensation for services rendered as a member of the MiNK Therapeutic Inc.'s Board of Directors. |